Literature DB >> 23026030

MicroRNAs and neurodegeneration: role and impact.

Masashi Abe1, Nancy M Bonini.   

Abstract

Neurodegenerative diseases are typically late-onset, progressive disorders that affect neural function and integrity. Although most attention has been focused on the genetic underpinnings of familial disease, mechanisms are likely to be shared with more predominant sporadic forms, which can be influenced by age, environment, and genetic inputs. Previous work has largely addressed the roles of select protein-coding genes; however, disease pathogenesis is complicated and can be modulated through not just protein-coding genes, but also regulatory mechanisms mediated by the exploding world of small non-coding RNAs. Here, we focus on emerging roles of miRNAs in age-associated events impacting long-term brain integrity and neurodegenerative disease.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23026030      PMCID: PMC3540990          DOI: 10.1016/j.tcb.2012.08.013

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN: 0962-8924            Impact factor:   20.808


  100 in total

1.  MicroRNA-195 downregulates Alzheimer's disease amyloid-β production by targeting BACE1.

Authors:  Hong-Can Zhu; Li-Mei Wang; Miao Wang; Bo Song; Song Tan; Jun-Fang Teng; Dong-Xiao Duan
Journal:  Brain Res Bull       Date:  2012-06-19       Impact factor: 4.077

2.  Normal midbrain dopaminergic neuron development and function in miR-133b mutant mice.

Authors:  Mary P Heyer; Amar K Pani; Richard J Smeyne; Paul J Kenny; Guoping Feng
Journal:  J Neurosci       Date:  2012-08-08       Impact factor: 6.167

3.  MicroRNA pathways modulate polyglutamine-induced neurodegeneration.

Authors:  Julide Bilen; Nan Liu; Barrington G Burnett; Randall N Pittman; Nancy M Bonini
Journal:  Mol Cell       Date:  2006-10-06       Impact factor: 17.970

4.  Hsa-miR-34b is a plasma-stable microRNA that is elevated in pre-manifest Huntington's disease.

Authors:  Philip Michael Gaughwin; Maciej Ciesla; Nayana Lahiri; Sarah J Tabrizi; Patrik Brundin; Maria Björkqvist
Journal:  Hum Mol Genet       Date:  2011-03-19       Impact factor: 6.150

5.  Protein binding of a DRPLA family through arginine-glutamic acid dipeptide repeats is enhanced by extended polyglutamine.

Authors:  H Yanagisawa; M Bundo; T Miyashita; Y Okamura-Oho; K Tadokoro; K Tokunaga; M Yamada
Journal:  Hum Mol Genet       Date:  2000-05-22       Impact factor: 6.150

6.  A novel synonymous SNP in PITX3 is associated with Parkinson's disease in Chinese population.

Authors:  Yaxing Gui; Yijia Zhao; Hai Liu; Jiang Fu; Zhongping Xu; Xingyue Hu
Journal:  Swiss Med Wkly       Date:  2012-03-09       Impact factor: 2.193

7.  Gene dysregulation in Huntington's disease: REST, microRNAs and beyond.

Authors:  Rory Johnson; Noel J Buckley
Journal:  Neuromolecular Med       Date:  2009-05-21       Impact factor: 3.843

8.  Dicer inactivation leads to progressive functional and structural degeneration of the mouse retina.

Authors:  Devid Damiani; John J Alexander; Jason R O'Rourke; Mike McManus; Ashutosh P Jadhav; Constance L Cepko; William W Hauswirth; Brian D Harfe; Enrica Strettoi
Journal:  J Neurosci       Date:  2008-05-07       Impact factor: 6.167

9.  The bifunctional microRNA miR-9/miR-9* regulates REST and CoREST and is downregulated in Huntington's disease.

Authors:  Amy N Packer; Yi Xing; Scott Q Harper; Lesley Jones; Beverly L Davidson
Journal:  J Neurosci       Date:  2008-12-31       Impact factor: 6.167

10.  Circulatory miR34a as an RNAbased, noninvasive biomarker for brain aging.

Authors:  Xiaoli Li; Amit Khanna; Na Li; Eugenia Wang
Journal:  Aging (Albany NY)       Date:  2011-10       Impact factor: 5.682

View more
  90 in total

1.  MicroRNAs in ALS: small pieces to the puzzle.

Authors:  Silvia Bicker; Gerhard Schratt
Journal:  EMBO J       Date:  2015-09-14       Impact factor: 11.598

Review 2.  Genomic integrity and the ageing brain.

Authors:  Hei-man Chow; Karl Herrup
Journal:  Nat Rev Neurosci       Date:  2015-10-14       Impact factor: 34.870

3.  Long-term exposure to black carbon, cognition and single nucleotide polymorphisms in microRNA processing genes in older men.

Authors:  Elena Colicino; Giulia Giuliano; Melinda C Power; Johanna Lepeule; Elissa H Wilker; Pantel Vokonas; Kasey J M Brennan; Serena Fossati; Mirjam Hoxha; Avron Spiro; Marc G Weisskopf; Joel Schwartz; Andrea A Baccarelli
Journal:  Environ Int       Date:  2015-12-24       Impact factor: 9.621

Review 4.  Role of microRNAs in the trabecular meshwork.

Authors:  Pedro Gonzalez; Guorng Li; Jianming Qiu; Jing Wu; Coralia Luna
Journal:  J Ocul Pharmacol Ther       Date:  2014-01-02       Impact factor: 2.671

5.  Microdissection and transcriptional profiling: a window into the pathobiology of preclinical prion disease.

Authors:  Anna Majer; Stephanie A Booth
Journal:  Prion       Date:  2014 Jan-Feb       Impact factor: 3.931

6.  miR-151-5p modulates APH1a expression to participate in contextual fear memory formation.

Authors:  Xu-Feng Xu; You-Cui Wang; Liang Zong; Xiao-Long Wang
Journal:  RNA Biol       Date:  2019-01-29       Impact factor: 4.652

Review 7.  Exosome platform for diagnosis and monitoring of traumatic brain injury.

Authors:  Douglas D Taylor; Cicek Gercel-Taylor
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-09-26       Impact factor: 6.237

Review 8.  The emerging roles of microRNAs in the pathogenesis of frontotemporal dementia-amyotrophic lateral sclerosis (FTD-ALS) spectrum disorders.

Authors:  Eduardo Gascon; Fen-Biao Gao
Journal:  J Neurogenet       Date:  2014-02-10       Impact factor: 1.250

9.  Multiplexed microRNA Expression Profiling by Combined Asymmetric PCR and Label-Free Detection using Silicon Photonic Sensor Arrays.

Authors:  Richard M Graybill; Maria C Cardenosa-Rubio; Hongwei Yang; Mark D Johnson; Ryan C Bailey
Journal:  Anal Methods       Date:  2018-03-23       Impact factor: 2.896

Review 10.  Integrating the roles of long and small non-coding RNA in brain function and disease.

Authors:  G Barry
Journal:  Mol Psychiatry       Date:  2014-01-28       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.